Q/C Technologies, Inc. (QCLS): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2019-12-31, 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$9.85M

Year ended 2025-12-31

-$14.15M

Trailing 12 months to 2026-06-30

2013-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	-$9.85M	n/m	2026-04-15, From 2025-01-01
2024-12-31	-$10.17M	n/m	2026-04-15, From 2024-01-01
2023-12-31	-$17.12M	n/m	2025-04-11, From 2023-01-01
2022-12-31	-$15.28M	n/m	2024-04-01, From 2022-01-01
2021-12-31	-$28.81M	n/m	2023-03-31, From 2021-01-01
2020-12-31	-$9.49M	n/c	2022-03-31, From 2020-01-01
2019-12-31	-$3.47M	n/c	2021-03-01, From 2019-01-01
2018-12-31	-$10.06M	n/m	2020-03-25, From 2018-01-01
2017-12-31	-$6.61M	n/m	2019-04-01, From 2017-01-01
2016-12-31	-$3.33M	n/m	2018-07-13, From 2016-01-01
2015-12-31	-$9.68M	n/m	2017-04-11, From 2015-01-01
2014-12-31	-$3.20M	n/m	2016-03-30, From 2014-01-01
2013-12-31	-$1.81M	n/a	2015-03-23, From 2013-01-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
Q/C Technologies, Inc. (QCLS)	2025-12-31	-$9.85M	n/m
Immucell Corp (ICCC)	2025-12-31	$1.65M	n/m
Anbio Biotechnology (NNNN)	2025-12-31	$5.77M	+189.1%
Insight Molecular Diagnostics Inc. (IMDX)	2025-12-31	-$51.12M	n/m
Alpha Teknova, Inc. (TKNO)	2025-12-31	-$16.98M	n/m
Cardio Diagnostics Holdings, Inc. (CDIO)	2025-12-31	-$6.48M	n/m
Volitionrx Ltd (VNRX)	2025-12-31	-$21.74M	n/m
Biomerica Inc (BMRA)	2026-05-31	-$5.32M	n/m
Aspira Women's Health Inc. (AWHL)	2025-12-31	-$7.91M	n/m

Compare QCLS, ICCC, NNNN, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗